Given our meta-analysis results which show an association of ER+ breast cancer risk with slow life history characteristics, ER + tumor that are categorized as ER- tumors might introduce errors that limit our capacity to detect an association of ER- breast cancer with fast life history characteristics. This evidence concerns the gene ESR1 and breast carcinoma.